Altamira Therapeutics Ltd. Gains 20.93%

Fri, Mar 10, 2023 at 07:07 PM
Altamira Therapeutics Ltd. Gains 20.93%

Altamira Therapeutics Ltd. (CYTO:NASDAQ) soared at $1.56, representing a gain of 20.9%. On Fri, Mar 10, 2023, CYTO:NASDAQ touched a New 2-Week Intraday Low of $1.2. The stock appeared on our News Catalysts scanner on Fri, Mar 03, 2023 at 09:52 AM in the 'BIOTECH' category. From Fri, Feb 24, 2023, the stock recorded 40.00% Up Days and 27.27% Green Days

The stock spiked on Fri, Mar 03, 2023 at $5.08 with a volume of 26M+.

About Altamira Therapeutics Ltd. (CYTO:NASDAQ)

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.